BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 20+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs.
Our focus on scientific excellence and rapid execution aim to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, and Raleigh, with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zurich, Switzerland, and are expanding across Europe.
To learn more about our story and company culture, visit us at https://bridgebio.com
The Sr. Director, Global Regulatory Affairs Labeling collaborates closely with BridgeBio regulatory teams and is a subject matter expert to support the development and implementation of regulatory labeling strategies and oversight of the global labeling activities. The incumbent will partner with the Regulatory Affairs, Medical Affairs, Legal, Clinical Development, Commercial and International distributors and lead the Label Working Group. Working creatively and independently, you will support and facilitate cross-functional efforts to meet the company goals within BridgeBio and across BridgeBio affiliates as needed.
No matter your role at BridgeBio, successful team members are:
Aquaconx Solutions
Aquaconx Solutions
etaily
Valnet
Overture Rede